![Laxminarayan Bhat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laxminarayan Bhat
Oprichter bij
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Vermogen: 78 130 $ op 30-06-2026
Profiel
Dr. Laxminarayan Bhat is a President, Chief Executive Officer & Director at Reviva Pharmaceuticals Holdings, Inc. and a President, Chief Executive Officer & Director at Reviva Pharmaceuticals, Inc. He is on the Board of Directors at Reviva Pharmaceuticals Holdings, Inc. and Reviva Pharmaceuticals, Inc. Dr. Bhat was previously employed as a Research Scientist by ARYx Therapeutics, Inc. and a Research Scientist by XenoPort, Inc. He received his doctorate degree from North-Eastern Hill University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-03-2026 | 124.213 ( 0,97% ) | 78 130 $ | 30-06-2026 |
Actieve functies van Laxminarayan Bhat
| Bedrijven | Functie | Begin |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Oprichter | 11-12-2020 |
Reviva Pharmaceuticals, Inc.
 Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Oprichter | 01-01-2006 |
Eerdere bekende functies van Laxminarayan Bhat
| Bedrijven | Functie | Einde |
|---|---|---|
| ARYX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 02-01-2006 |
| XENOPORT, INC. | Hoofd Techniek/Wetenschap/O&O | 02-01-2004 |
Opleiding van Laxminarayan Bhat
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Health Technology |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
North-Eastern Hill University
 North-Eastern Hill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reviva Pharmaceuticals Holdings, Inc.
 Reviva Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system, cardio vascular, metabolic and inflammatory diseases | Health Technology |
Kies MarketScreener 
